Recent Advances in Neurosurgery: When Surgery Is Needed

Neurosurgery is needed when conservative treatment has reached its limit: medication no longer controls the pain, doses climb until side effects appear, or a neurological deficit such as limb weakness or bladder involvement develops. Recent advances in neurosurgery have made the operation itself far smaller, but they have not changed that test. Deciding when surgery is needed remains a judgement about timing, made against clear thresholds.

Dr. Anil Kumar Kansal, Vice Chairman & HOD - Neuro Surgery & Neuro Spine, BLK-Max Super Speciality Hospital, New Delhi, India, works across the whole range of these advances. Problems that once required a large opening of the skull or spine are now treated through a burr hole (a small opening drilled in the skull), a tube a few millimetres wide, a percutaneous needle passed through the skin or, in the case of radiosurgery, no incision at all. His account is notable for two things: the precision with which he defines who each technique is for, and his insistence that the decision to operate is as much a clinical judgement about timing as a technical one.

This guide maps the advances he covered across neurosurgery, then sets out the principles that run through all of them: who should not be operated on, when conservative treatment has had its turn, how the costs compare with the alternatives, and how care should be shared between the specialist and the patient's own doctor.

Recent advances in neurosurgery: spine, brain and function

The advances fall into three groups: smaller-access spine surgery with guided hardware, endoscopic and image-guided brain surgery, and functional procedures that restore function when medication fails.

The spine: smaller access, guided hardware

For disc herniation, Dr. Kansal lists three developments: the endoscope, laser, and percutaneous, endoscopic and minimally invasive lumbar disc surgery. Alongside these sit kyphoplasty (cement placed inside a collapsed vertebra) for osteoporotic compression fractures, artificial disc replacement in the cervical spine, single-screw fixation of odontoid fractures and robot-guided screw placement. The selection criteria for each, the red flags that move a patient towards early surgery, and his framework for deciding when an older patient should stop managing pain with tablets are covered in when a herniated disc needs surgery, and which operation suits which patient.

The brain: seeing more through less

In cranial surgery the gains come from a layered toolkit. The endoscope treats hydrocephalus and removes colloid cysts through a single burr hole. Stereotactic frames, frameless navigation, fluorescent dye and intraoperative MRI let the surgeon localise a lesion before opening and confirm complete removal during the operation. Chemotherapy wafers placed in the tumour cavity and Gamma Knife radiosurgery extend treatment to disease surgery alone cannot control. These are set out in brain tumour surgery techniques, from navigation to Gamma Knife.

Functional neurosurgery: restoring function when medication fails

Trigeminal neuralgia and Parkinson's disease share a pattern. Medication works first, then demands higher doses, produces side effects or stops working, and surgery becomes the better option. Dr. Kansal's practice for trigeminal neuralgia has moved decisively to microvascular decompression, an operation that separates a blood vessel from the nerve it compresses. For Parkinson's disease he places deep brain stimulation, in which electrodes implanted in the brain are driven by a pacemaker-like device, at a specific point in the course of the illness. Both, along with focused ultrasound, are covered in trigeminal neuralgia treatment and deep brain stimulation.

Who should not have neurosurgery: three absolute contraindications

Dr. Kansal will not operate, whatever the condition being treated, on a patient with any of three absolute contraindications:

• Significant cardiac disease.
• A bleeding or coagulation disorder.
• Any severe infection elsewhere in the body.

Every advance above still carries the risks of anaesthesia and surgery, and each of these conditions describes a patient in whom the operation itself becomes the larger danger. Outside them, the question is not whether surgery is possible but whether it is needed now, which is a matter of timing.

When is neurosurgery needed? A timed decision, not a competing philosophy

Surgery is needed at a specific point in an illness: once the patient stops responding to medication, develops drug side effects or finds daily life seriously compromised. Before that point, conservative care leads.

A question raised in the masterclass Live Discussion was whether a patient should stay with a neurologist's conservative care or go to a surgeon. Dr. Kansal rejects the framing. In his view this is a combined discipline: neurologist and neurosurgeon work together and follow the results, and the question is not which specialist is right but what the patient needs at a given point.

Parkinson's disease illustrates the principle. In roughly the first five years, while drugs control the symptoms well, the neurologist leads and no surgery is needed. Surgery has a role once the patient stops responding to medication, develops drug side effects or finds daily life seriously compromised. Trigeminal neuralgia follows the same logic in a shorter time frame: if pain is controlled on minimal doses, Dr. Kansal does not operate unless the patient asks for it; if pain persists despite medication, he proceeds.

The same discipline applies to spinal nerve compression. He uses concrete thresholds rather than a general impression of severity: a patient who needs two or three painkillers a day, cannot carry out daily activities or cannot walk 500 metres is worth considering for surgery. The result is a decision that can be explained to the patient and reproduced by the referring doctor.

Neurosurgery cost in India: what the procedures cost and what they replace

At Dr. Kansal's centre in New Delhi, microvascular decompression costs around USD 6,000 to 7,000, spine surgery around USD 7,000 and deep brain stimulation around USD 30,000 to 40,000. The figures he gave were:

• Microvascular decompression for trigeminal neuralgia: around USD 6,000 to 7,000.
• Spine surgery without robotic assistance: around USD 7,000, with robotic screw placement adding about USD 1,000 to 2,000. Quotations from other Indian hospitals are summarised under spinal decompression and fixation surgery cost.
• Deep brain stimulation: around USD 30,000 to 40,000.
• Chemotherapy wafers for recurrent glioblastoma: he described these as costly, without giving a figure.

Is surgery cheaper than long-term medication?

He consistently compares the price of surgery with the cost of not operating rather than with zero. For trigeminal neuralgia, he estimates that within about six months, the cost of medication matches the cost of the operation, so a durable surgical result is also the cheaper path over time. For an older patient with nerve compression who could continue on physiotherapy and tablets, he makes the same argument: long-term medication will cost the same or more after some time, while surgery offers the better long-term result. For robotic spine surgery, he regards the extra cost as minor against the value of correctly placed screws, because a single misplaced screw can undo an otherwise good operation.

This framing matters for families paying out of pocket. A one-off procedure with a high and lasting success rate can be more economical than years of partial relief on medication that still leaves a patient unable to work through the bad days.

Shared care between the specialist and the local doctor

Care should run from the local doctor to the specialist and back again. Dr. Kansal describes the proper sequence as primary, then secondary, then tertiary: the patient starts with the local doctor and reaches the specialist through that doctor. After surgery the direction reverses. A patient who returns home needs the local doctor for every kind of help, and a post-operative complication that arises there cannot be managed from a hospital in Delhi.

For that reason he wants referring doctors to feel free to contact his team whenever they face a problem with a patient. He follows the same practice with patients who come from small towns within India: they go back to their local doctor, and his team stays in touch. In his words, the target is not surgery; it is treating the patient.

Treatment based on requirement, not volume

Dr. Kansal sets two conditions for a cross-border referral pathway. First, treatment should be based on requirement: the surgeon does only what the patient needs. Second, what is done should be done perfectly.

These two conditions are also the thread through the clinical material in this series. Kyphoplasty suits osteoporotic fractures with an intact posterior wall. Percutaneous disc surgery is reserved for contained discs. Deep brain stimulation waits until medication has reached its limit. Microvascular decompression is offered when drugs no longer control the pain, not before. The advances are real, and their value depends on applying each one to the patient it was designed for.

A separate masterclass by Dr. Kansal addresses the risk side of the same field: spine and brain surgery complication rates, realistic recovery and spinal cord injury care.